Insider · CIK 0001898521
Kate Rochlin
cooofficer
Files at INAB (IN8BIO, INC.). First filing -, latest -.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 0
$0 bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
No scored open-market trades yet.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 22, 2025 | INAB IN8BIO, INC. | AGrant or award Common Stock | +7,247 | $1.38 | $10k | 9,085 | Dec 23, 2025 |
| Apr 30, 2025 | INAB IN8BIO, INC. | MOption exercise Common Stock | +12,295 | $0.18 | $2,267 | 55,169 | May 7, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | DDisposition to issuer Series A Warrants (right to buy)derivative | -12,295 | - | - | 0 | May 7, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | AGrant or award Series A Warrants (right to buy)derivative | +12,295 | - | - | 12,295 | May 7, 2025 |
| Apr 30, 2025 | INAB IN8BIO, INC. | MOption exercise Series A Warrants (right to buy)derivative | -12,295 | $0.00 | $0 | 0 | May 7, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | DDisposition to issuer Series B Warrants (right to buy)derivative | -12,295 | - | - | 0 | May 7, 2025 |
| Apr 27, 2025 | INAB IN8BIO, INC. | AGrant or award Series B Warrants (right to buy)derivative | +12,295 | - | - | 12,295 | May 7, 2025 |
| Feb 5, 2025 | INAB IN8BIO, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +338,950 | $0.00 | $0 | 338,950 | Feb 7, 2025 |
| Dec 19, 2024 | INAB IN8BIO, INC. | AGrant or award Employee Stock Option (right to buy)derivative | +302,839 | $0.00 | $0 | 302,839 | Dec 23, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.